Published in AIDS on May 24, 2002
Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. J Clin Immunol (2003) 0.98
HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Clin Exp Immunol (2004) 0.96
Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy. BMC Infect Dis (2006) 0.87
Increased interleukin-7 plasma levels are associated with recovery of CD4+ T cells in HIV-infected children. J Clin Immunol (2003) 0.85
Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy. J Allergy Clin Immunol (2006) 0.80
Direct analysis of thymic function in children with Down's syndrome. Immun Ageing (2005) 0.75
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis (2006) 1.07
Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors. Antimicrob Agents Chemother (2011) 0.92
Neuroprotective effects of early antiretrovirals in vertical HIV infection. Pediatr Neurol (2003) 0.92
Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1. Biopolymers (2013) 0.82
Reconstructing the course of HIV-1-associated progressive encephalopathy in children. Med Sci Monit (2002) 0.78
Stopping antiretroviral therapy in 'prematurely treated' HIV-1-infected children with full viral supression is safe. AIDS (2006) 0.75